JP2023170425A - Assembled body of plurality of rod-like chemical volatilizing bodies - Google Patents

Abstract

To provide an assembled body of a plurality of rod-like chemical volatilizing bodies that can be produced at a low cost.SOLUTION: An assembled body 20 is constituted of a piece of cardboard 22 that has six chemical volatilizing bodies 16 and extends on a plane. The cardboard 22 exhibits a rectangular form consisting of a pair of short sides 2002 and a pair of long sides 2004, in a plan view. The six chemical volatilizing bodies 16 are arranged in a direction orthogonal to their length L direction while their length L direction is made parallel in the cardboard 22. The six chemical volatilizing bodies 16 are arranged such that side faces of the chemical volatilizing bodies 16 positioned at both ends in a width W direction face with each other. The side faces of the adjacent chemical volatilizing bodies 16 are connected by cut-off parts 24 that can be cut off, and the cut-off parts 24 linearly extend in the length L direction.SELECTED DRAWING: Figure 3

Description

The present invention relates to an assembly of a plurality of rod-shaped drug volatilization bodies.

Conventionally, various chemical volatilizers have been provided, and Patent Documents 1, 2, 3, and 4 disclose a container having an opening at the top and containing a volatile chemical, and a container that is inserted into the container from the opening. A drug volatilizer is provided that includes a plurality of rod-shaped drug volatilizers whose lower portions are immersed in the drug and whose upper portions protrude above the container from an opening.
In a drug volatilization device using a rod-shaped drug volatilization body, the drug volatilization body sucks up the drug in the container, and the drug is volatilized from a portion of the drug volatilization body that protrudes upward from the container.
Rod-shaped drug volatilizers made of wood, rattan, bamboo, and resin are available.

Japanese Patent Application Publication No. 2020-188974 Japanese Patent Application Publication No. 2021-176537 Utility model registration No. 3119834 Japanese Patent Application Publication No. 2011-212271

On the other hand, when using such rod-shaped drug volatilization bodies, the plurality of rod-shaped drug volatilization bodies are placed in a box or the like together with a container containing the medicine, and then packaged and distributed on the market. If the volatile matter is separated into pieces, it will look bad when taken out of the box and the product value will decrease.
Therefore, in the past, the number of rod-shaped drug volatilization bodies was accurately counted and sealed in a transparent bag, or they were tied together with a binding tool and placed in a box together with a container, and then packaged and distributed on the market.
However, the task of putting together a plurality of rod-shaped chemical volatilizers is a time-consuming task, and there is a problem in that the chemical volatilizer is inevitably expensive.
The present invention has been devised in view of the above circumstances, and an object of the present invention is to provide an assembly of a plurality of rod-shaped drug volatilization bodies that can be easily manufactured at low cost.

In order to achieve the above-mentioned object, one embodiment of the present invention is an assembly of a plurality of rod-shaped drug volatilization bodies that volatilize a drug, the assembly being formed of a single thin plate-shaped base. , the plurality of drug volatilization bodies are arranged in the base in a direction perpendicular to the length direction with their length directions parallel to each other, and adjacent drug volatilization bodies are connected to each other by a detachable part. It is characterized by the presence of
Further, in an embodiment of the present invention, a cross section of the drug volatilization body cut along a plane perpendicular to the length direction thereof has a flat rectangular shape with a width larger than a thickness, and the plurality of drug volatilization bodies are The side surfaces of the drug volatilizing body located at both ends in the width direction face each other, and the separation part connects the opposing side surfaces.
Further, in one embodiment of the present invention, the base body has a rectangular shape in a plan view, and the plurality of drug volatilization bodies are arranged on the base body through the separation part, and the length of the plurality of drug volatilization bodies is Both ends in the transverse direction are located on a pair of short sides of the rectangle.
Further, an embodiment of the present invention is characterized in that the drug volatilization body is made of cardboard, and the base body is made of cardboard.
Further, in an embodiment of the present invention, the separating portion includes a breakable connection portion that connects the adjacent drug vaporizing bodies and a cut that separates the neighboring drug vaporizing bodies from each other. It is characterized by the presence of
Further, in an embodiment of the present invention, the plurality of rod-shaped drug volatilization bodies are inserted into a container containing volatile drugs at one end side in the length direction of the drug volatilization bodies, and the drug volatilization bodies are The other end in the length direction of the volatilization body is used as a drug volatilizer that projects above the container, and the connection portion is provided only at a location where the drug volatilization body is inserted into the container. It is characterized by
Further, in one embodiment of the present invention, the connecting portion is configured to connect an end portion in the length direction of the drug volatilization body and a 1/1/2 length of the total length of the drug volatilization body from the lengthwise end portion of the drug volatilization body. In the case where the drug volatilizing body is provided at two locations 3 apart apart from each other and the thickness of the drug volatilizing body is 0.4 mm to 0.6 mm, in the length direction of the drug volatilizing body at the connecting portion provided at the two locations. Both lengths are about 0.5 mm.
Further, in an embodiment of the present invention, the plurality of rod-shaped drug volatilization bodies are inserted into a container containing volatile drugs at one end side in the length direction of the drug volatilization bodies, and the drug volatilization bodies are The other end side in the length direction of the volatilization body is used as a drug volatilizer that protrudes above the container, and the connection part is connected to a part of the volatilization body inserted into the container and a part of the volatilization body that protrudes from the container. The length along the length direction of the drug volatilization body of the connecting portion provided at the location of the drug volatilization body that is protruded from the container and the part of the drug volatilization body that is protruded from the container is The connecting portion provided at the location of the drug vaporizing body to be inserted is formed with a dimension shorter than the length along the length direction of the drug vaporizing body.
Further, in an embodiment of the present invention, the connection portion provided at a location of the drug volatilization body inserted into the container is connected to one end in the length direction of the drug volatilization body and the drug volatilization body. The connecting portions are provided at two locations, one end in the length direction and a location 1/3 of the total length of the drug vaporization body, and the connection portion is provided at a location of the drug vaporization body that protrudes from the container. , provided at one location near the other end in the length direction of the drug volatilization body, and when the thickness of the drug volatilization body is 0.4 mm to 0.6 mm, the drug volatilization body inserted into the container; The length of the connecting part provided at one end in the length direction is about 0.5 mm, and the part is inserted into the container and is located 1/3 of the total length of the drug volatilization body from the one end. The length of the connecting portion provided at the container is approximately 0.4 mm, and the length of the connecting portion provided near the other end in the length direction of the drug volatilization body protruding from the container is: It is characterized by being about 0.3 mm.

According to the assembly of the embodiment of the present invention, the substrate is punched with a blade die to simultaneously produce the drug volatilizer, or the drug volatilizer is manufactured using a molding machine. Since the aggregate is manufactured at the same time, it is possible to easily and reliably manufacture an aggregate in which a plurality of rod-shaped drug volatilization bodies are arranged in a separable manner to form a single member at low cost.
Therefore, as in the past, it takes time and effort to accurately count the number of multiple rod-shaped chemical vaporizers and seal them in a transparent bag, or to bind multiple rod-shaped chemical vaporizers with a binding tool. The work can be omitted, and an assembly of multiple rod-shaped chemical volatilization bodies can be easily manufactured at low cost. This is advantageous in increasing the sales volume of chemical volatilizers using volatilizers.
Further, according to the assembly of one embodiment of the present invention, it is possible to easily produce an assembly of drug volatilization bodies having a rectangular cross section and extending in a long and narrow shape, which is excellent in design, and is easy to print with designs. It will be advantageous above.
Further, according to the aggregate according to an embodiment of the present invention, if the aggregate is formed from a single flat and thin plate-like rectangular base, the aggregate does not become bulky and a large space is required to be secured. Since there are no chemical vaporizers, it can be easily inserted into the box together with the container, and the packaging box can be kept to a minimum size, which is advantageous in reducing the cost of the chemical volatilizer. This is advantageous in increasing sales volume, and it is also advantageous in easily manufacturing an aggregate of drug volatilization bodies having a rectangular cross section and the same length extending in an elongated shape.
According to the assembly according to an embodiment of the present invention, if the drug volatilization body is made of cardboard, cardboard can be used as the base, and by punching a single piece of cardboard with a Thomson blade die, multiple assemblies can be made efficiently. Good and easily manufactured.
In the present invention, various conventionally known materials such as those made of wood, rattan, and bamboo can be used as the chemical volatilization body. However, if the chemical volatilization body is made of cardboard, Compared to using chemical volatilizers made of wood, rattan, bamboo, or resin, multiple processing steps and dedicated molding machines can be omitted, so it is environmentally friendly while reducing chemical volatilization. This is advantageous in significantly reducing the cost of the body and the chemical volatilizer, and it is advantageous in significantly increasing the sales volume of the chemical volatilizer and the chemical volatilizer.
In addition, if a cardboard material is used as the chemical volatilizer, the suction speed and volatilization rate of the chemical will be almost uniform, and the volatilization effect of the chemical will be reliably demonstrated, which will increase the practical value and commercial value of the chemical volatilizer. It will be advantageous.
In addition, the separating portion of the present invention may have a structure in which a perforation is formed by making a cut in a dotted line shape at a place where the cardboard parts of adjacent drug vaporizing bodies are connected, or Various conventionally known structures can be adopted, such as a structure in which the part where the parts are connected is formed of a thin part with a wall thickness smaller than that of the drug volatilization body. If the structure is made up of a combination of a breakable connecting part where the parts are connected and a cut that separates the adjacent drug vaporizing bodies from each other, multiple drug vaporizing bodies can be manufactured at the same time by punching cardboard with a Thomson blade. Since the assembly can be manufactured easily and reliably, it is advantageous in manufacturing the assembly at low cost.
In addition, if the connection part is provided only at the part of the drug volatilization body that is inserted into the container, unevenness will not occur in the part of the drug volatilization body that protrudes from the container due to separation, and the connection part will not be broken. Since the resulting unevenness is located inside the container, it becomes less noticeable, which is advantageous in improving the design and aesthetics of the drug volatilizer.
In this case, the connection parts may be provided at two locations: at the end in the length direction of the drug volatilizer and at a location 1/3 of the total length of the drug volatilizer from the lengthwise end of the drug volatilizer. When the thickness of the drug volatilization body is 0.4 mm to 0.6 mm, it is preferable that the lengths of the two connecting portions are both about 0.5 mm.
In addition, if the length of the connection part is long, it is possible to prevent the drug volatilization material from coming apart from the aggregate due to vibration shock during manufacturing and marketing, but the connection part may be broken when the drug volatilization material is separated. The unevenness caused by this will be noticeable and may be disadvantageous in terms of improving the design of the drug volatilization body. Therefore, the length of the connection part provided at the part of the drug volatilization body that protrudes from the container should be It is preferable that the length of the connection part is shorter than the length of the connection part provided at the location of the drug volatilization body.
In this case, if the thickness of the drug volatilization body is 0.4 mm to 0.6 mm, the connection part provided at the location of the drug volatilization body inserted into the container is connected to one end in the length direction of the drug volatilization body. , the connecting portion is provided at two locations, from one end in the length direction of the drug volatilization body to a location 1/3 of the total length of the drug volatilization body, and is provided at a location on the drug volatilization body that protrudes from the container. It is provided at one location near the other end in the length direction of the drug volatilization body. The length of the connection part provided at one end in the length direction of the drug volatilization body is about 0.5 mm, and the connection part is provided at a location 1/3 of the total length of the drug volatilization body from the one end. The length of the connection part is about 0.4 mm, and the length of the connection part provided near the other end in the length direction of the drug volatilization body protruding from the container is about 0.3 mm. preferable.

FIG. 3 is a perspective view of the chemical volatilization device in use. It is a perspective view of a chemical|medical agent volatilization body. (A) and (B) are respectively plan views of the aggregate. It is an explanatory view of manufacturing a plurality of aggregates from one piece of cardboard. It is a top view of an aggregate. (A) and (B) are respectively plan views of the aggregate. (A) and (B) are respectively plan views of the aggregate. (A) and (B) are explanatory views of manufacturing a plurality of aggregates from a single sheet of cardboard, respectively.

First, a chemical volatilization device using an assembly of a plurality of rod-shaped chemical volatilization bodies will be described, and then an embodiment of an assembly of a plurality of chemical volatilization bodies made of cardboard according to the present invention will be described.
As shown in FIG. 1, the drug volatilizer 10 includes a container 14 containing a volatile liquid drug 12, and a plurality of cardboard drug volatilizers 16 inserted into the container 14. There is.
A fragrance, an insect repellent, an insecticide, etc. are used as the drug 12, and in this embodiment, a fragrance 12A is used as the drug 12.
The fragrance 12A is composed of a single fragrance component or a mixture of a fragrance component and a volatile solvent, and is a transparent liquid in this embodiment.

The container 14 is made of synthetic resin or glass, and is transparent in this embodiment.
The container 14 accommodates the drug 12 and has a large diameter portion 1402 and a small diameter portion 1404 provided above the large diameter portion 1402. The upper end of the small diameter portion 1404 forms a circular opening 1406. ing.
When the chemical volatilizer 10 is on the market, the aromatic agent 12A is stored as the chemical 12 in the container 14, and a cap (not shown) is removably attached to the opening 1406. When the chemical volatilizer 10 is used, the cap is removed from the opening 1406. It is removed and the container 14 is placed at an appropriate location.

The drug volatilization body 16 has an elongated rod shape, is inserted into the container 14 through the opening 1406, the lower part is immersed in the aromatic agent 12A within the container 14, and the upper part is used by protruding above the container 14 through the opening 1406.
The drug volatilization body 16 is a member that sucks up the aromatic agent 12A from a portion immersed in the aromatic agent 12A by capillary action, and volatilizes the aromatic agent 12A from a portion exposed from the liquid surface of the aromatic agent 12A.
The cross section of the chemical volatilization body 16 may be circular or square, and various conventionally known shapes can be applied to the cross section of the chemical volatilization body 16.

The chemical vaporization body 16 is made of cardboard.
Cardboard is thicker paper than commonly used paper, and paper is made by tightly intertwining plant fibers in water, stretching them into a thin, flat shape, dehydrating them, and drying them. The type of paper is not particularly limited, and coated paper, high-quality paper, matte paper, art post paper, kraft paper, matte post paper, and Kent paper are used. In this embodiment, recycled paper (50% waste paper) is used. Recycled paper is recycled paper, and is preferable from the perspective of preserving the forest environment.
In this embodiment, the drug volatilization body 16 extends in a belt shape with a flat rectangular cross section.
Further, in the present embodiment, the drug volatilization body 16 has a uniform width W of about 5 mm, a length L of about 180 mm, and a uniform thickness T of about 0.5 mm, which is smaller than the width W, and has a straight line. Note that the length L and width W of the drug volatilization body 16 are determined as appropriate depending on the size of the container 14, and the length L of the drug volatilization body 16 used in the present invention ranges from 100 mm to 240 mm, the thickness T is 0.3 mm to 1 mm, and the width W is 3 mm to 10 mm.
Moreover, a pattern 18 is printed on one side of the drug volatilization body 16 in the length L direction on at least one surface of both ends in the thickness T direction.
Here, the design 18 is a concept including letters, patterns, characters, and the like.
The ink used for printing is appropriately selected, but it is desirable to use a pigment so that it does not bleed due to the absorbed aromatic agent 12A.
The printing method is appropriately selected from offset printing, gravure printing, flexo printing, etc.
Note that, as will be described later, the chemical volatilization body 16 is placed in the container 14 and used in an inclined state, so its cross-sectional area, length, etc. The basis weight is determined appropriately.
Further, the basis weight of the chemical volatilization body 16 is appropriately determined so that it can absorb the aromatic agent 12A.

The chemical volatilizer 16 exhibits a light color such as light blue, light yellow, light orange, light pink, light brown, or light gray when the aromatic agent 12A is not permeated. In the deep state, these colors change to dark blue, dark yellow, dark orange, dark pink, dark brown, and dark gray, respectively. The pattern 18 is formed in a color close to the color of the chemical volatilization material soaked with the aromatic liquid 12A.
In this embodiment, the chemical volatilization body 16 is light brown in a state in which the aromatic agent 12A is not permeated, and the pattern 18 is formed in dark brown. The volatile material 16 changes color from light brown to dark brown, and is formed so that the pattern 18 becomes difficult to see.
Further, at the end of use of the chemical volatilizer 10 in which the aromatic agent 12A has been used up, the chemical volatilizer 16 dries and becomes light brown again, and the pattern 18 is formed so as to be visible.

The method of using the chemical volatilizer 10 is as follows.
The aromatic agent 12A is housed in the container 14, a cap is removably attached to the opening 1406, and a plurality of chemical volatilizers 16 are placed in a box together with the container 14, packaged, and distributed on the market.
When using the drug volatilizer 10, the purchaser removes the cap from the opening 1406, puts a plurality of drug volatilizers 16 into the container 14 through the opening 1406, and places the container 14 at an appropriate location.
In this case, since the pattern 18 printed on one side of the drug volatilization body 16 in the length L direction is visible when the drug volatilization body 16 is first taken out of the box, the user may notice that the area where the pattern 18 is printed is located above the container 14. A plurality of chemical volatilization bodies 16 are put into the container 14 from the opening 1406 so that the lower part thereof is immersed in the aromatic agent 12A.

Eventually, the aromatic agent 12A is sucked up by the chemical volatilization body 16, and the color of the chemical volatilization body 16 changes from light brown to dark brown from the bottom to the top, making the pattern 18 difficult to visually recognize.
The aromatic components of the aromatic agent 12A are volatilized into the room from the locations of the plurality of chemical volatilization bodies 16 exposed above the liquid level of the aromatic agent 12A.
When the aromatic agent 12A in the container 14 is used up and all the aromatic components of the aromatic agent 12A sucked into the plurality of chemical volatilization bodies 16 are volatilized, the use of the chemical volatilizer 10 is completed.
When the chemical volatilizer 10 is finished using, the plurality of chemical volatilizers 16 dry and return to light brown color, and the pattern 18 becomes visible again, so the user can visually check the remaining amount of the aromatic agent 12A in the container 14. By visually recognizing the pattern 18 on the chemical volatilizing body 16 without stopping, it can be determined that the chemical volatilizing device 10 has been used.
In the present invention, various conventionally known materials can be used as the material constituting the drug volatilization body 16, but by making the drug volatilization body 16 made of cardboard, the drug can be easily and reliably removed by cutting the cardboard. The volatilization body 16 can be manufactured, and compared to the case where the chemical volatilization body 16 is made of wood, rattan, bamboo, or resin, multiple processing steps and a dedicated molding machine can be omitted, so it is environmentally friendly. While still being effective, it is advantageous in significantly reducing the cost of the chemical volatilization body 16 and the chemical volatilization device 10, and is advantageous in significantly increasing the sales volume of the chemical volatilization body 16 and the chemical volatilization device 10.
Furthermore, when the chemical volatilization body 16 is made of wood, rattan, or bamboo, the suction speed and volatilization rate vary because they are natural materials, but when the chemical volatilization body 16 is made of cardboard, the chemical 12 The suction speed and volatilization rate become almost uniform, and the volatilization effect of the chemical 12 is reliably exhibited, which is advantageous in increasing the practical value and commercial value of the chemical volatilizer 10.
Further, in this embodiment, the drug volatilization body 16 extends in a band shape with a flat rectangular cross section, which is advantageous in improving the aesthetic appearance of the drug volatilization body 16 and the drug volatilization device 10.
In addition, since the drug volatilization body 16 has a flat rectangular cross section, extends linearly in a belt shape, and is made of cardboard, the pattern 18 can be easily printed on the drug volatilization body 16 and the drug volatilization body 16. This is even more advantageous in improving the design and aesthetics of the vessel 10.
In addition, the pattern 18 is visible when the fragrance 12A is not permeated into the chemical volatilizer 16, becomes difficult to see when the chemical volatilizer 10 is used, and becomes visible again at the end of use, so, for example, Even if the container 14 is opaque and the remaining amount of the aromatic agent 12A in the container 14 can be visually confirmed only through the opening 1406, the user can check the amount of the aromatic agent 12A remaining in the container 14 without visually checking it through the opening 1406. By visually checking the color of the body 16, it can be known that the time has come for the end of use of the chemical volatilizer 10, which is advantageous in improving the usability of the chemical volatilizer 10.
Furthermore, if the chemical volatilizer 16 is formed with a flat rectangular cross section, the container 14 may tilt when moving the installation location of the chemical volatilizer 10, or the container 14 may be subjected to vibrations when the chemical volatilizer 10 is used in a car. However, the volatilization properties of the drug 12 and This is advantageous in maintaining the design and aesthetics of the chemical volatilizer 10.

Next, the aggregate 20 of the drug volatilization bodies 16 will be explained.
In the present embodiment, six drug volatilizers 16 are used in the drug volatilizer 10.
The drug volatilization bodies 16 have a uniform width W (5 mm), a uniform thickness T (0.5 mm), and extend linearly with a uniform length L (180 mm), and the shapes of the six drug volatilization bodies 16 are all the same. , which is an elongated rectangle in plan view.
As shown in FIGS. 3A and 3B, the assembly 20 is composed of a base made of a piece of cardboard 22 that has six drug volatilization bodies 16 and extends on a single plane. .
The cardboard 22 constituting the base has a rectangular shape consisting of a pair of short sides 2002 and a pair of long sides 2004 in plan view.
The six drug volatilization bodies 16 are arranged in the cardboard 22 in a direction perpendicular to the length L direction with the length L direction parallel to each other.
Specifically, the six drug volatilization bodies 16 are arranged between a pair of long sides 2002 of the rectangle, with their length L direction parallel to the long side 2002, and their width W direction parallel to the short side 2002 of the rectangle. The six drug volatilization bodies 16 are arranged so that both ends in the length L direction are located on the pair of short sides 2002 of the rectangle, and therefore, the thickness of the cardboard 22 is the same as the thickness T of the drug volatilization bodies 16. becomes.
The six drug volatilization bodies 16 are arranged so that the side surfaces of the drug volatilization bodies 16 located at both ends in the width W direction face each other.

The side surfaces of adjacent drug volatilization bodies 16 are connected by a separable separation part 24, and the separation part 24 extends linearly in the length L direction.
The separation section 24 may be configured as a single connection section 24 in which a cut is made in the shape of a dotted line to form a perforation at a location where the cardboard portions of adjacent drug volatilization bodies 16 are connected. Alternatively, the connection portion 24 may be configured in combination with a cut 24B that separates adjacent drug volatilization bodies 16 from each other. Alternatively, a single connecting portion 24 may be formed in which the cardboard portions of adjacent drug vaporizing bodies 16 are connected to each other as a thin wall portion smaller than that of the drug vaporizing bodies 16, or this connecting portion 24 and Various conventionally known structures can be adopted for the separation part 24, such as a structure in combination with the cut 24B.
In the present embodiment, the separation portion 24 is connected to at least one breakable connection portion 24A provided at intervals in the length L direction and to which cardboard portions of adjacent drug volatilization bodies 16 are connected, and a connection portion 24A. It is constituted by a cut 24B that is provided at a location other than 24A and separates adjacent drug volatilization bodies 16 from each other.
As shown in FIG. 4, the assembly 20 having such cut-off portions 24 is produced by punching out a piece of cardboard 2202 larger than the cardboard 22 with a Thomson blade die, so that multiple pieces of the assembly 20 can be manufactured at the same time as the drug volatilization body 16. Manufactured. Furthermore, by stacking a plurality of sheets of cardboard 2202 and punching them with a Thomson blade die, several times the amount of the aggregate 20 can be manufactured in one punching process.
The purchaser of the drug volatilizer 10 takes out the single assembly 20 from the box, breaks the separation part 24 to separate the six drug volatilizers 16 from the assembly 20, and opens the plurality of drug volatilizers 16 into the opening 1406. The chemical volatilizer 10 is used with the container 14 placed at an appropriate location.
The drug volatilizing body 16 is separated from the aggregate 20 by moving the drug volatilizing body 16 placed at the end of the aggregate 20 in the width W direction of the chemical volatilizing body 16 in a direction away from the aggregate 20 and separating it. Alternatively, the drug vaporizing body 16 may be separated by swinging in a fan shape using the longitudinal end of the drug vaporizing body 16 as a fulcrum, or the drug vaporizing body 16 may be separated so as to overlap with the assembly 20 side with the separation part 24 as a boundary. You can optionally bend it and cut it off.

According to the assembly 20 of this embodiment, a plurality of rod-shaped chemical volatilization bodies 16 are lined up so that they can be separated by punching out a plurality of mutually stacked cardboard sheets 2202 using a Thomson blade die. This is because a plurality of aggregates 20, each of which is a single member in which the connecting portion 24A does not break and the drug volatilizing body 16 does not come apart due to vibrations or shocks during transportation, are manufactured at the same time when the drug volatilizing body 16 is manufactured. , the assembly 20 can be easily and reliably manufactured at low cost.
Therefore, it is possible to omit the conventional work of enclosing a plurality of rod-shaped chemical volatilization bodies in a transparent bag or tying them together with a binding tool, and moreover, it is possible to manufacture the aggregate 20 at low cost. This is advantageous in reducing the cost of the drug volatilization device 10 using a plurality of drug volatilization bodies 16, and is advantageous in increasing the sales volume of the drug volatilization device 10 using a plurality of drug volatilization bodies 16. .
In addition, since the assembly 20 is formed of a single piece of cardboard 22 extending on a plane, it is not bulky and does not require a large space, so it can be easily inserted into a box together with the container 14, and the box to be packed. can be minimized in size, which is advantageous in reducing the cost of the chemical volatilization device 10, and is advantageous in increasing the sales volume of the chemical volatilization device 10 using a plurality of chemical volatilization bodies 16.

The present inventor has discovered that, according to the present embodiment, the drug volatilizing body 16 does not come apart due to vibration or shock during manufacturing or transportation, and the drug volatilizing body 16 can be smoothly separated from the aggregate 20. Although the object and effect of the present invention of being able to easily and reliably manufacture the body 20 at low cost has been achieved, the structure of the separation portion 24 was further studied.
That is, if the length of the connecting portion 24A in the L direction is large, the unevenness caused by the breaking of the connecting portion 24A becomes noticeable when the connecting portion 24A is separated.
However, since the drug volatilization body 16 is used with one side in the length L direction inserted into the inside of the container 14, when the connection portion 24A is provided at the location of the drug volatilization body 16 inserted into the container 14, the connection portion Even if the length of the connecting portion 24A in the L direction is increased, the unevenness caused by the breaking of the connecting portion 24A becomes less noticeable.
For this reason, the inventor conducted various tests on the case where the thickness of the cardboard 22 was 0.5 mm.

In the assembly 20 shown in FIG. 3(A), a connecting portion 24A having a length of 0.5 mm is located at a location 1 mm away from one end in the length L direction of the drug volatilization body 16 inserted into the container 14. A connecting portion 24A with a length of 0.5 mm is provided at a location 58 mm away from this connecting portion 24A (a location 1/3 of the length L of the drug volatilization body 16 from one end). A cut-off portion 24 is provided with a cut 24B at a location other than the above.
That is, the plurality of connecting portions 24A are provided only at the locations where the drug volatilization body 16 is inserted into the container 14.
According to the assembly 20 shown in FIG. 3(A), the chemical volatilization body 16 can be smoothly separated from the assembly 20, and the connecting portion 24A will not break due to vibration or impact during manufacturing or transportation, and the assembly Since the body 20 can be prevented from coming apart, and the two connecting parts 24A are all provided at the locations of the drug volatilization body 16 inserted into the container 14, unevenness caused by the breaking of the connecting parts 24A is not noticeable. There was no.

In the assembly 20 shown in FIG. 3(B), a connecting portion 24A with a length of 0.5 mm is provided at one end in the length L direction of the drug volatilization body 16 inserted into the container 14, and a connecting portion 24A with a length of 0.5 mm A connecting portion 24A with a length of 0.4 mm is located at a location 59.5 mm away from one end in the length L direction (a location 1/3 of the length L of the drug volatilization body 16 from one end). A connecting part 24A with a length of 0.3 mm is provided at a location 20 mm away from the other end in the length L direction and closer to the other end, and a cutoff part with a cut 24B at a location other than the connecting part 24A. 24 were established.
In other words, in the assembly 20 shown in FIG. 3(B), a plurality of connection parts 24A are provided at the location of the drug volatilization body 16 inserted into the container 14, and a plurality of connection parts 24A are provided at the location of the drug volatilization body 16 that protrudes from the container 14. The length of the connecting portion 24A is shorter than the length of the connecting portion 24A provided at the location of the drug volatilizing body 16 inserted into the connecting portion 14.
According to the aggregate 20 shown in FIG. 3(B), the chemical volatilization body 16 can be smoothly separated from the aggregate 20, and the aggregate 20 can be prevented from coming apart due to vibration or impact during manufacturing or transportation. Since the two connecting portions 24A are provided at the locations of the drug volatilizing body 16 inserted into the container 14, the unevenness caused by the breaking of the connecting portions 24A will not be noticeable and will not protrude from the container 14. Since the connecting portion 24A provided at the location of the drug volatilization body 16 had a short length of 0.3 mm, the unevenness caused by the breaking of the connecting portion 24A was not noticeable.
In the assembly 20 shown in FIG. 3(B), a connecting portion 24A is also provided on the other end side in the length L direction of the drug volatilization body 16 protruding from the container 14, so that the connection portion 24A shown in FIG. 3(A) Compared to the aggregate 20, it is advantageous in maintaining a more stable state in which the plurality of drug volatilization bodies 16 are arranged, and in preventing the drug volatilization bodies 16 from spreading out in a fan shape.
In addition, in the assembly 20 shown in FIGS. 3(A) and 3(B), a connecting portion 24A having a length of 0.5 mm, which is larger than 0.3 mm, is provided at one end of the drug volatilizing body 16 in the length L direction. In addition, connecting portions 24A with lengths of 0.5 mm and 0.4 mm, which are larger than 0.3 mm, are provided at a location 1/3 of the length L of the drug volatilization body 16 from one end. This is because when the chemical volatilizer 10 is used, the unevenness caused by the breaking of the connecting portion 24A is inserted into the interior of the container 14, and is difficult to see from the outside even if the container 14 is transparent.

In the assembly 20 shown in FIG. 5, a connecting portion 24A having a length of 0.5 mm is provided at a distance of 19.5 mm from one end in the length L direction of the drug volatilizing body 16 inserted into the container 14. Three cut-off parts 24 were provided, and cuts 24B were formed at locations other than the three connection parts 24A.
The three connecting portions 24A are provided at locations where the drug volatilization body 16 is inserted into the container 14.
In the assembly 20 shown in FIG. 5, it is possible to prevent the assembly 20 from coming apart due to vibration impact during manufacturing and market distribution, and the chemical volatilization body 16 can be smoothly separated from the assembly 20, and the three connecting parts 24A Since these were all provided at the locations of the drug volatilization body 16 inserted into the container 14, the unevenness caused by the breakage of the connecting portion 24A was not noticeable.

In the assembly 20 shown in FIG. 6(A), a connecting portion 24A with a length of 0.3 mm is provided at one end in the length L direction of the drug volatilizing body 16 inserted into the container 14, and a connecting portion 24A with a length of 0.3 mm is connected to the connecting portion 24A. A connecting portion 24A with a length of 0.3 mm is located at a location near one end in the length L direction (a location 1/3 of the length L of the drug volatilization body 16 from one end), 59.7 mm apart. A cut-off portion 24 is provided in which a cut 24B is formed at a portion other than the connection portion 24A.
Even with the aggregate 20 shown in FIG. 6(A), it is possible to prevent the aggregate 20 from coming apart due to vibration impact during manufacturing and market distribution, and the chemical volatilization body 16 can be smoothly separated from the aggregate 20, and the two Since all of the connecting parts 24A were provided at the locations of the drug volatilizing body 16 inserted into the container 14, the unevenness caused by the breaking of the connecting parts 24A was not noticeable.

In the assembly 20 shown in FIG. 6(B), the connecting portions 24A, 24A of the assembly 20 shown in FIG. A disconnection section 24 is provided in which a connecting section 24A having a length of 0.3 mm is added to the above.
The length of the added connecting portion 24A is set to 0.3 mm because the added connecting portion 24A is located above the container 14, so the length of the added connecting portion 24A is set to 0.3 mm, so the length of the added connecting portion 24A is set to 0.3 mm. This is to make it less noticeable.
Even in the aggregate 20 shown in FIG. 6(B), it is possible to smoothly separate the chemical volatilization body 16 from the aggregate 20, and in the aggregate 20 shown in FIG. In addition, since the connecting portion 24A is added to the location of the drug volatilization body 16 located above the container 14, a plurality of drug volatilization bodies 16 are arranged side by side compared to the assembly 20 shown in FIG. 6(A). This is advantageous in maintaining a more stable state and preventing the chemical volatilization body 16 from spreading in a fan shape, and is more advantageous in preventing the aggregate 20 from coming apart.

In the cutoff portion 24 of the aggregate 20 shown in FIG. 7(A), the length of the lowermost connecting portion 24A of the aggregate 20 shown in FIG. 6(B) is changed from 0.3 mm to 0.5 mm. .
Even in the aggregate 20 shown in FIG. 7(A), the chemical volatilization body 16 can be smoothly separated from the aggregate 20, and in the aggregate 20 shown in FIG. In addition, since the length of the connecting portion 24A at the location of the drug volatilization body 16 inserted into the container 14 is changed from 0.3 mm to 0.5 mm, compared to the assembly 20 shown in FIG. 6(B), This is more advantageous in maintaining a more stable state in which the plurality of drug volatilization bodies 16 are lined up and preventing the aggregate 20 from coming apart.
In the separation part 24 of the assembly 20 shown in FIG. 7(B), the lowermost connecting part 24A shown in FIG. A connecting portion 24A with a length of 0.3 mm is added in the middle of the connecting portion 24A provided at the location. A connecting portion 24A is added thereto.
Even in the aggregate 20 shown in FIG. 7(B), the chemical volatilization body 16 can be smoothly separated from the aggregate 20, and in the aggregate 20 shown in FIG. In addition, since it has a configuration in which a connecting portion 24A with a length of 0.3 mm is added to the location of the drug volatilization body 16 inserted into the container 14, multiple drugs can be This is more advantageous in maintaining the arrangement of the volatile bodies 16 in a more stable state and preventing the aggregate 20 from coming apart.

The strength of the connecting portion 24A that connects adjacent drug volatilization bodies 16 becomes stronger as the cross-sectional area of the connecting portion 24A becomes larger, and decreases as the cross-sectional area becomes smaller. It is proportional to the length and thickness of the volatilization body 16, and the greater the strength of the connecting portion 24A, the more noticeable the unevenness that occurs when it is broken.
Therefore, when providing the connecting portion 24A between the part of the drug volatilizing body 16 inserted into the container 14 and the part of the drug volatilizing body 16 protruding from the container 14, in order to make the unevenness that occurs when it is broken less noticeable, It is preferable that the length of the connecting portion 24A provided at the location of the drug volatilization body 16 protruding from the container 14 is shorter than the length of the connection portion 24A provided at the location of the drug volatilization body 16 inserted into the container 14.
Furthermore, in this embodiment, since the thickness T of the chemical volatilization body 16 is 0.5 mm, the connecting portions 24A having lengths of 0.5 mm, 0.4 mm, and 0.3 mm were used.
The thickness T of the chemical volatilizer used in the present invention is 0.3 mm to 1 mm, and when the thickness T is smaller than 0.5 mm, the length of the connecting portion 24A becomes larger than the above value, and the thickness If T is greater than 0.5 mm, the length of the connecting portion 24A will be smaller than the above value.
Therefore, when the thickness T of the chemical volatilization body is approximately 0.4 mm to 0.6 mm, the length of the connecting portion 24A along the L direction is appropriately selected from approximately 0.3 mm to 0.5 mm. It is preferable.

In addition, according to the assembly 20 having the separation part 24 of the present embodiment, the drug volatilization body 16 can be easily separated from the assembly 20, and the connection part 26A will not break due to vibration or impact during manufacturing or transportation. Although it has been found that the disintegration of the aggregate 20 can be prevented, the same effect can be obtained by increasing the number of connecting parts 24A having a length of 0.3 mm in addition to the aggregate 20 of this embodiment. Various shapes of the cut-off portions 24 can be considered, and the present invention is of course applied to the assembly 20 having the cut-off portions 24 of various shapes.
Further, in the above embodiment, the case is described in which the aggregate 20 is a plurality of drug volatilizing bodies 16 extending linearly, but the extending direction of the drug volatilizing bodies 16 is not limited to the linear shape, and the direction shown in FIG. An aggregate 20 of a plurality of drug volatilizing bodies 16 extending in an S-shape as shown in FIG. It may also be a body 20, in which case the cut-off portion 24 would also extend in an S-shape, a bent shape, or the like.
When the drug volatilization body 16 extends in a bent shape or an S-shape, a larger surface area of the drug volatilization body 16 can be ensured than when the drug volatilization body 16 extends in a straight line. This is advantageous in increasing the volatilization effect.

10 Chemical vaporizer 12 Chemical agent 12A Air freshener 14 Container 1402 Large diameter portion 1404 Small diameter portion 1406 Opening 16 Chemical vaporizer 18 Pattern 20 Aggregate 2002 Short side 2004 Long side 22, 2202 Cardboard 24 Separation portion 24A Connection portion 24B Cut

Claims (9)

An aggregate of a plurality of rod-shaped drug volatilization bodies that volatilize a drug,
The aggregate is formed of a single thin plate-like substrate,
The plurality of drug volatilization bodies are arranged in the base in a direction perpendicular to the length direction with their length directions parallel to each other,
Adjacent said drug volatilization bodies are connected to each other by a separable separation part,
An aggregate of a plurality of rod-shaped drug volatilization bodies characterized by: A cross section of the drug volatilization body taken along a plane perpendicular to its length direction has a flat rectangular shape with a width greater than its thickness;
The plurality of drug volatilization bodies are arranged such that side surfaces of the drug volatilization bodies located at both ends in the width direction face each other,
The separation portion connects the opposing side surfaces,
The aggregate of a plurality of rod-shaped drug volatilization bodies according to claim 1. The base body has a rectangular shape in plan view,
The plurality of drug volatilization bodies are arranged on the base body through the separation part, and both ends of the plurality of drug volatilization bodies in the length direction are located on the pair of short sides of the rectangle.
The aggregate of a plurality of rod-shaped drug volatilization bodies according to claim 2. The drug volatilization body is made of cardboard,
the base is made of cardboard;
The aggregate of a plurality of rod-shaped drug volatilization bodies according to claim 3. The separation part is configured to include a breakable connection part that connects the adjacent drug volatilization bodies and a cut that separates the adjacent drug volatilization bodies from each other.
The aggregate of a plurality of rod-shaped drug volatilization bodies according to any one of claims 1 to 4. The plurality of rod-shaped drug volatilization bodies are inserted into a container containing a volatile drug at one end in the length direction of the drug volatilization bodies, and at the other end in the length direction of the drug volatilization bodies. used as a drug volatilizer whose side protrudes above the container;
The connection portion is provided only at a location where the drug volatilization body is inserted into the container.
The aggregate of a plurality of rod-shaped drug volatilization bodies according to claim 5. The connection portions are provided at two locations: at an end in the length direction of the drug volatilization body, and at a location 1/3 of the total length of the drug volatilization body from the lengthwise end of the drug volatilization body. ,
When the thickness of the drug volatilization body is 0.4 mm to 0.6 mm,
The lengths of the connecting portions provided at the two locations along the length direction of the drug volatilization body are both about 0.5 mm;
The assembly of a plurality of rod-shaped drug volatilization bodies according to claim 6. The plurality of rod-shaped drug volatilization bodies are inserted into a container containing a volatile drug at one end in the length direction of the drug volatilization bodies, and at the other end in the length direction of the drug volatilization bodies. used as a drug volatilizer whose side protrudes above the container;
The connection portion is provided at a location where the drug volatilization body is inserted into the container and at a location where the drug volatilization body is protruded from the container,
The length along the length direction of the drug volatilization body of the connection portion provided at a location of the drug volatilization body protruding from the container is the same as the length of the connection portion provided at a location of the drug volatilization body inserted into the container. The connecting portion is formed with a dimension shorter than the length along the length direction of the drug volatilizing body,
The aggregate of a plurality of rod-shaped drug volatilization bodies according to claim 5. The connection portion provided at the location of the drug volatilization body inserted into the container includes one end in the length direction of the drug volatilization body and a connection portion from one end in the length direction of the medicine volatilization body to the It is installed in two places, one at 1/3 of the total length of the drug volatilization body,
The connection portion provided at a location of the drug volatilization body protruding from the container is provided at one location near the other end in the length direction of the drug volatilization body,
When the thickness of the drug volatilization body is 0.4 mm to 0.6 mm,
The length of the connection part provided at one end in the length direction of the drug volatilization body inserted into the container is about 0.5 mm,
The length of the connecting part inserted into the container and provided at a location 1/3 of the total length of the drug volatilization body from the one end is about 0.4 mm,
The length of the connecting portion provided near the other end in the length direction of the drug volatilization body protruding from the container is approximately 0.3 mm;
The aggregate of a plurality of rod-shaped drug volatilization bodies according to claim 8.

Images